Trump policies 'promise' an economic downturn: Prominent forecaster
Wall Street is reacting to the Federal Reserve's decision leave interest rates unchanged. Meanwhile, the UCLA Anderson Forecast warns that President Trump's policies, if fully enacted, will lead to a recession. NBC News senior business correspondent Christine Romans, Washington Post opinion columnist and MSNBC host Catherine Rampell and Brendan Buck, former Press Secretary to House Speakers Paul Ryan and John Boehner, join Chris Jansing to discuss.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week
IQVIA Holdings experienced a 10% rise in share price over the last week, correlating with its recent developments, notably the dosing of the first patient in the RENEW Phase 2 trial and its strategic alliance with Sarah Cannon Research Institute to optimize oncology trials. These initiatives likely provided a positive sentiment boost, aligning well with the broader market momentum, as indices such as the S&P 500 also reached new highs. The market's anticipation over US-China trade talks and overall strong corporate earnings have supported the upward trend, further enhancing IQV's market performance. We've identified 1 warning sign for IQVIA Holdings that you should be aware of. Uncover 18 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. The recent 10% rise in IQVIA Holdings' share price has been influenced by important developments like the dosing in the RENEW Phase 2 trial and a key alliance with Sarah Cannon Research Institute. These initiatives are expected to potentially drive revenue growth, particularly as the strategic alliance optimizes oncology trials. The company's past performance, with total returns of 10.45% over five years, suggests modest growth in investor value. However, compared to the US Life Sciences industry's one-year return of 27% decline, IQVIA's recent rise highlights positive market sentiment. These initiatives, combined with FDA reforms and NVIDIA collaboration, may lower operational costs and have a favorable impact on earnings forecasts. Analysts predict revenue to grow by 5.2% annually over the next three years, which is somewhat cautious compared to the general expectations for the life sciences sector. The recent share price movement to US$146.2 remains below the consensus price target of US$216.31, indicating potential for future appreciation if the projected growth in revenue and earnings materializes. Click here to discover the nuances of IQVIA Holdings with our detailed analytical financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:IQV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
13 minutes ago
- CNBC
The copper market shows how tariffs are putting traders and businesses in a bind
Lingering uncertainty over the 90-day suspension of President Trump's high tariffs could scramble some traditional market signals as traders and businesses try to get ahead of government policy. Copper is one asset caught up in such a push-pull scenario, according to Morgan Stanley. The metal, sometimes referred to as " Dr. Copper ," has a history of serving as a leading economic indicator due to its wide use in industry. Viewed from that lens, it should be bolstering confidence on Wall Street right now. The front-month contract for copper futures has gained more than 5% since early May — though it is still well below its high of the year reached in late March, right before tariff fears shook markets. @HG.1 YTD mountain Copper futures are trending higher over the past month, though still below the highs of the year. Equities tied to copper are also doing well, with Freeport-McMoRan up more than 11% over the past month, and Southern Copper higher by 8%. However, reality may not be that simple. Amy Gower, commodities strategist at Morgan Stanley, said in a note to clients Tuesday that several factors are muddying the picture for copper, including "front-loading" from U.S. companies who are buying up the metal now, before potential new tariffs take effect. "Copper faces diverging market forces. [London Metal Exchange] inventories are depleting rapidly as copper is pulled to the U.S., boosting timespreads and prices, but China market signals are weakening, suggesting downside risks to come," Gower said. In February, President Donald Trump signed an executive order directing the Commerce Department to look into the possible need for tariffs on copper. That levy would be separate from, and possibly in addition to, the tariffs on shipments from individual countries. If companies keep buying up copper for fear of future tariffs, that could create an "upward squeeze," Gower said. But the supply-demand picture could also change quickly and pull prices down instead. "Already in April, China exported 77kt of copper, and this will likely have continued in May/June, which may provide some relief to LME inventories. On top [of that], the strong solar installations (+70% YTD in Jan-April) are expected to slow from June as new power tariffs come in ... while U.S. demand will slow if copper tariffs are announced," Gower said. — CNBC's Michael Bloom contributed reporting.
CNBC
17 minutes ago
- CNBC
Trump's CFTC pick calls for comprehensive crypto rules in nomination hearing: CNBC Crypto World
On today's episode of CNBC Crypto World, major cryptocurrencies climb as investors wait for more insight on trade discussions between the U.S. and China. Plus, Brian Quintenz, President Trump's pick to lead the U.S. Commodity Futures Trading Commission, prepares to testify before the Senate. And, Matt Hougan, Bitwise Asset Management CIO, discusses the launch of the asset manager's new GameStop-focused covered call ETF.
